Protalix BioTherapeutics - 23 Year Stock Price History | PLX

Historical daily share price chart and data for Protalix BioTherapeutics since 1998 adjusted for splits. The latest closing stock price for Protalix BioTherapeutics as of September 23, 2021 is 1.37.
  • The all-time high Protalix BioTherapeutics stock closing price was 875.00 on May 18, 1998.
  • The Protalix BioTherapeutics 52-week high stock price is 7.02, which is 412.4% above the current share price.
  • The Protalix BioTherapeutics 52-week low stock price is 1.28, which is 6.6% below the current share price.
  • The average Protalix BioTherapeutics stock price for the last 52 weeks is 3.33.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Protalix BioTherapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 3.2313 3.5800 6.4500 1.3100 1.3700 -62.26%
2020 3.4829 3.5600 4.6100 2.1000 3.6300 10.67%
2019 3.5303 3.4000 5.5000 1.7560 3.2800 5.47%
2018 5.1844 6.9390 7.5200 2.9450 3.1100 -52.96%
2017 7.8780 4.1530 14.4000 4.0500 6.6120 48.58%
2016 6.8047 10.1000 10.2000 2.8520 4.4500 -56.37%
2015 16.5446 18.7000 23.4000 7.8000 10.2000 -44.57%
2014 34.1525 39.6000 52.6000 18.0000 18.4000 -52.70%
2013 50.3766 54.0000 61.5000 37.2000 38.9000 -25.05%
2012 57.2596 50.0000 72.0000 48.0000 51.9000 5.27%
2011 64.8742 104.1000 104.6000 43.6000 49.3000 -50.60%
2010 75.6167 69.0000 100.0000 58.4000 99.8000 50.76%
2009 53.2214 18.5000 121.4000 18.0000 66.2000 259.78%
2008 25.4462 34.6000 37.0000 9.6000 18.4000 -45.88%
2007 229.9124 271.5000 457.2000 32.0000 34.0000 -79.64%
2006 378.3625 406.0000 539.0000 152.0000 167.0000 -60.71%
2005 47.9270 20.0000 511.0000 13.0000 425.0000 2025.00%
2004 25.6667 40.0000 40.0000 20.0000 20.0000 -50.00%
2003 21.0833 11.0000 51.0000 11.0000 40.0000 263.64%
2002 23.4921 23.0000 38.0000 11.0000 11.0000 -52.17%
2001 24.8557 19.0000 40.0000 15.0000 23.0000 22.99%
2000 32.0927 88.0000 94.0000 6.0000 18.7000 -78.63%
1999 95.3274 188.0000 263.0000 6.0000 87.5000 -61.11%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.062B $0.063B
Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71